Read more at Financial Times.
Novo Nordisk faces US congressional grilling over price of weight loss drugs
Date: |
Topics
-
The Wall Street Journal - Business
The Price War in Weight-Loss Drugs Is Here
Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price tags of over $1,000 a month.2 days ago -
Financial Times - Business
US drug ‘gatekeepers’ face FTC antitrust lawsuit over insulin prices
Complaint alleges pharmacy benefit managers owned by CVS, Cigna and UnitedHealth are keeping prices high2 days ago -
CBS News - Top stories
Inside the thriving market for alternatives to brand-name weight loss drugs
High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the meantime, a market for cheaper, compounded drugs thrives.Yesterday -
CBS News - Top stories
As weight loss drugs explode in popularity, are online marketplaces safe?
Weight loss drugs are exploding in popularity, with 1 in 8 Americans saying they have tried medications like Ozempic and Wegovy to tackle everything from diabetes to weight loss, among other ...Yesterday -
MarketWatch - Business
FTC sues prescription-drug middlemen over insulin prices, says drugmakers are also ‘on notice’
Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, regulator alleges.2 days ago -
The New York Times - Health
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.2 days ago -
The Wall Street Journal - Business
FTC Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms of inflating the price of insulin.2 days ago -
CNBC - Business
FTC sues drug middlemen for allegedly inflating insulin prices
The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts.Yesterday -
NBC News - Top stories
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.2 days ago
More from Financial Times
-
Financial Times - World
Europe goes to UNGA fretting over Ukraine and climate progress
Also in this newsletter: Brussels drops environmental complaint about Greek oil drilling projects2 hours ago -
Financial Times - World
FirstFT: World’s biggest banks pledge support for COP28 nuclear power goal
Also in today’s newsletter, US warns Israel and Big Read on Trumponomics2 hours ago -
Financial Times - World
Commerzbank warns UniCredit merger is threat to German businesses
German bank says potential multibillion tie-up with Italian rival could hit lending to Mittelstand companies3 hours ago - Germany -
Financial Times - World
At Milan Fashion Week, hope for hard times
Designers at Bottega Veneta, Diesel and Versace sought to give their clothes new meaning3 hours ago -
Financial Times - World
Markets fall before close elections and surge after, study shows
Research Affiliates found that political affiliation of the winning party has less bearing than tightness of race3 hours ago